April 25, 2024
| Trial | CT7001_003 |
|---|---|
| Cancer Type | Breast Cancer |
| Hospital(s) | Belfast City Hospital |
| Information | A Phase 1b/2 Open-label Study of Samuraciclib in Combination with Elacestrant in Participants with |